JPMORGAN CHASE & CO - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 44 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
51
-98.6%
0.00%
Q1 2022$8,000
-95.7%
3,641
-94.8%
0.00%
Q3 2021$185,000
+14.9%
69,740
+71.1%
0.00%
Q2 2021$161,000
-55.3%
40,761
-46.0%
0.00%
Q1 2021$360,000
+666.0%
75,441
+1038.2%
0.00%
Q4 2020$47,000
+42.4%
6,628
+77.8%
0.00%
Q2 2020$33,000
-50.0%
3,727
-77.6%
0.00%
Q4 2019$66,000
-79.4%
16,633
-80.5%
0.00%
Q3 2019$321,00085,3240.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders